Involvement of a JAK/STAT pathway inhibitor: cytokine inducible SH2 containing protein in breast cancer

scientific article

Involvement of a JAK/STAT pathway inhibitor: cytokine inducible SH2 containing protein in breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/978-0-387-69080-3_30
P8608Fatcat IDrelease_5yft4pdjivdjtak4a5prvyo6fm
P698PubMed publication ID18497055

P2093author name stringJean Chiesa
Elara Moudilou
Mireille Raccurt
Hichem Mertani
Cécile Vouyovitch
Peter Lobie
Sahra Borgés
P407language of work or nameEnglishQ1860
P304page(s)321-329
P577publication date2008-01-01
P1433published inAdvances in Experimental Medicine and BiologyQ4686385
P1476titleInvolvement of a JAK/STAT pathway inhibitor: cytokine inducible SH2 containing protein in breast cancer
P478volume617

Reverse relations

cites work (P2860)
Q38383263A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer
Q90681858B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3
Q59238691Caffeic Acid Versus Caffeic Acid Phenethyl Ester in the Treatment of Breast Cancer MCF-7 Cells: Migration Rate Inhibition
Q39408258Downregulation of ER60 protease inhibits cellular proliferation by inducing G1/S arrest in breast cancer cells in vitro
Q38760796HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
Q47664414Influence of autocrine growth hormone on NF-κB activation leading to epithelial-mesenchymal transition of mammary carcinoma
Q33806855Polymorphisms in CISH gene are associated with persistent hepatitis B virus infection in Han Chinese population
Q37136960Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells
Q98164379Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence

Search more.